New milbemycin derivatives are alpha 7 nicotinic acetylcholine receptor modulators, useful e.g. for treating Alzheimer's disease, schizophrenia, nicotine and other drug addiction, pain, anxiety and depression

A Almond; Conformetrix Limited; CD Blundell; MG Barker

New milbemycin derivatives are alpha 7 nicotinic acetylcholine receptor modulators, useful e.g. for treating Alzheimer's disease, schizophrenia, nicotine and other drug addiction, pain, anxiety and depression

A Almond (Other), Conformetrix Limited (Other), CD Blundell (Other), MG Barker (Other)

Research output: Patent

Original language	English
Patent number	WO2012020258
Publication status	Published - 10 Aug 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{d016cf99d545458bb94c88c334394ab4,

title = "New milbemycin derivatives are alpha 7 nicotinic acetylcholine receptor modulators, useful e.g. for treating Alzheimer's disease, schizophrenia, nicotine and other drug addiction, pain, anxiety and depression",

author = "A Almond and Conformetrix Limited and CD Blundell and MG Barker",

year = "2010",

month = aug,

day = "10",

language = "English",

type = "Patent",

note = "WO2012020258",

}